Summary
E. I. du Pont de Nemours and Company (DuPont) and The Dow Chemical Company have jointly announced that the European Commission has initiated a Phase II review of their proposed merger of equals transaction. This development signifies a more in-depth examination by European regulators regarding the competitive implications of the proposed merger. While the initiation of a Phase II review is a standard part of the regulatory process for large mergers, it indicates that the European Commission has identified potential competition concerns that warrant further investigation. Investors should monitor this review closely as it could impact the timeline and conditions of the merger, or even its ultimate approval. The companies have stated they will cooperate fully with the European Commission's review.
Key Highlights
- 1E. I. du Pont de Nemours and Company (DuPont) and The Dow Chemical Company announced the European Commission has initiated a Phase II review for their proposed merger.
- 2The Phase II review signifies a deeper investigation into the potential competitive effects of the merger.
- 3This is a procedural step in the regulatory approval process for large transactions.
- 4The companies expect to cooperate fully with the European Commission's review.
- 5The filing references a joint press release dated August 11, 2016, as an exhibit.